312 related articles for article (PubMed ID: 25511114)
1. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
[TBL] [Abstract][Full Text] [Related]
2. Drug-Drug Interactions Among Hospitalized Children Receiving Chronic Antiepileptic Drug Therapy.
Lebowitz MB; Olson KL; Burns M; Harper MB; Bourgeois F
Hosp Pediatr; 2016 May; 6(5):282-9. PubMed ID: 27081190
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.
Dai D; Feinstein JA; Morrison W; Zuppa AF; Feudtner C
Pediatr Crit Care Med; 2016 May; 17(5):e218-28. PubMed ID: 26959349
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
5. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of polypharmacy exposure among hospitalized children in the United States.
Feudtner C; Dai D; Hexem KR; Luan X; Metjian TA
Arch Pediatr Adolesc Med; 2012 Jan; 166(1):9-16. PubMed ID: 21893637
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
8. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
[TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
11. Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East.
Gholaminezhad S; Hadjibabaie M; Gholami K; Javadi MR; Radfar M; Karimzadeh I; Ghavamzadeh A
Ann Hematol; 2014 Nov; 93(11):1913-22. PubMed ID: 24906215
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical significance of potential drug-drug interaction in hematopoietic stem cell transplantation.
Trevisan DD; Silva JB; Oliveira HC; Secoli SR; Lima MH
Cancer Chemother Pharmacol; 2015 Feb; 75(2):393-400. PubMed ID: 25542268
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
[No Abstract] [Full Text] [Related]
14. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals.
Antoon JW; Hall M; Herndon A; Carroll A; Ngo ML; Freundlich KL; Stassun JC; Frost P; Johnson DP; Chokshi SB; Brown CM; Browning WL; Feinstein JA; Grijalva CG; Williams DJ
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33037121
[TBL] [Abstract][Full Text] [Related]
15. The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients.
Feinstein JA; Feudtner C; Valuck RJ; Kempe A
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1049-57. PubMed ID: 26248529
[TBL] [Abstract][Full Text] [Related]
16. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
[TBL] [Abstract][Full Text] [Related]
17. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine.
Vonbach P; Dubied A; Krähenbühl S; Beer JH
Eur J Intern Med; 2008 Oct; 19(6):413-20. PubMed ID: 18848174
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments.
Fokter N; Mozina M; Brvar M
Wien Klin Wochenschr; 2010 Feb; 122(3-4):81-8. PubMed ID: 20213374
[TBL] [Abstract][Full Text] [Related]
20. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
